Peptides 101: from sequence to evidence
A practical starting point for understanding peptide science without mistaking a mechanism for a medical conclusion.
Educational information only — not medical advice. This page does not diagnose conditions, recommend treatment, or replace care from a qualified clinician. The Peptide Center uses an evidence-first editorial process: regulatory sources, trial registries, and peer-reviewed research take priority; uncertainty is stated rather than filled with promises.
Peptides are short chains of amino acids. In biology, they can act as signals, messengers, or building blocks in larger systems. That diversity explains why peptide research spans many fields—but it does not mean that every compound called a peptide has the same evidence, regulation, quality controls, or risk profile.
References
- Therapeutic peptides: recent advances in discovery, synthesis, and clinical applications. Signal Transduction and Targeted Therapy, 2022
- FDA: The drug development process
Related resources
Continue with curated, same-topic resources from the published library. These links are educational references, not treatment recommendations.
5-Amino-1MQ
An evidence-first reference for reading claims and source material about 5-Amino-1MQ.
Open resourcePeptide brief5-Amino-1MQ / SLU-PP-332
An evidence-first reference for reading claims and source material about 5-Amino-1MQ / SLU-PP-332.
Open resourcePeptide briefAlpha-Klotho mAb
An evidence-first reference for reading claims and source material about Alpha-Klotho mAb.
Open resourcePeptide briefAOD-9604
An evidence-first reference for reading claims and source material about AOD-9604.
Open resourcePeptide briefAOD-9604: interpreting a fragment-peptide claim
A framework for evaluating evidence and regulatory claims around an hGH-fragment research compound.
Open resourcePeptide briefARA-290
An evidence-first reference for reading claims and source material about ARA-290.
Open resourceArticleFDA approved, compounded, and unapproved are not synonyms
A plain-language map of product categories that are often blurred in peptide discussions.
Open resourceArticleHow to read a peptide study without overclaiming
A practical guide to research stage, controls, endpoints, uncertainty, and applicability.
Open resource